Nov Inc (NOV)

$12.80 -0.45 (-3.40%)
Market Cap 5.14B
Revenue (ttm) 8.87B
Net Income (ttm) 635.00M
EPS (ttm) N/A
PE Ratio 9.17
Forward PE 11.97
Profit Margin 7.16%
Debt to Equity Ratio 0.27
Volume 3,106,165
Avg Vol 3,916,350
Day's Range N/A - N/A
Shares Out 375.74M
Stochastic %K 62%
Beta 1.28
Analysts Sell
Price Target $16.25

Company Profile

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The Energy Equipment segment offers equipment and systems, spare parts, repair, and rentals; hydration units, chemical additive systems, blenders, and control systems, as well as centrifugal pumps, v...

Industry: Oil & Gas Equipment & Services
Sector: Energy
Phone: 346 223 3000
Website: www.nov.com
Address:
10353 Richmond Avenue, Houston, United States
Solaryellow
Solaryellow Jul. 15 at 12:54 PM
$IXHL third time Ive seen mention or reference, of an # $NOV buy or merger...
1 · Reply
TandoriAmerica
TandoriAmerica Jul. 11 at 11:36 PM
$NOV $150 2027 I said it here.
0 · Reply
Blackberry_Buzz
Blackberry_Buzz Jul. 10 at 5:39 PM
$NOV Good God. Someone just spent over $1.2M in premium for the Nov 14 strike calls & $100K for some Aug 16 strike calls today. You're now about the daily 89 moving average and 21 moving average. Looks strong.
0 · Reply
TheDayTradingAcademy
TheDayTradingAcademy Jul. 9 at 1:32 AM
European stock markets were higher on Tuesday, boosted by energy up +1.1%, due by higher crude prices & healthcare shares up +0.08%, with $NOV up +2%, while investors assessed the latest round of U.S. President Trump's tariff rollouts, which included a new deadline for trade deals which is Aug.01. French $CAC40 +0.56%, German $DAX +0.55%, Italian FTSE +0.67%, Spain’s Ibex +0.03%, London $FTSE +0.54% & European STOXX 600 +0.41% at 545.71, its highest level in 3 weeks.
0 · Reply
tnewman913
tnewman913 Jul. 1 at 7:07 PM
$NOV the adr for novo nordisk is NVO not NOV. NOV is energy, nerds.
0 · Reply
JarvisFlow
JarvisFlow Jul. 1 at 3:58 PM
Susquehanna has updated their rating for NOV ( $NOV ) to Positive with a price target of 18.
0 · Reply
Doozio
Doozio Jul. 1 at 4:23 AM
$HAL is fooked MRNA then PFE. Wait until $NOV.
0 · Reply
clan
clan Jun. 29 at 1:33 AM
$MNKD CLOFAZIMINE (CIS) by Mannkind ----------------------------------------------------- Designations: - Phase 3 ICoN-1 international trials • U.S.A. & Japan & Australia & Korea - Fast Tracked by FDA - Orpan Drug - Qualified Infectious Disease Product - Well tolerated - No significant Adverse Events - Localized treatment (lungs) - Improved patient adherence - Indications for arthritis & cancers - Current global mkt $2.1B [2023] ...and coming soon..... - - - Clofazimine DPI Partner with $GSK ? $NOV ? $ROCHE ? Maybe Merck.
1 · Reply
lenhat
lenhat Jun. 27 at 2:09 PM
$HIMS $NOV is a clown. Hims is a growing business💪
1 · Reply
smalltraderjoe
smalltraderjoe Jun. 25 at 9:40 PM
$HIMS $NOV sells wegovy which is nothing but a branded GLP-1. They were forcing $HIMS to sell only wegovy over $HIMS own compounded- GLP-1 . Over the period of time this practice would kill the profit of HIMS. $HIMS's custom GLP-1 products are not illegal and within the limit of FDA designated specs. Otherwise by this time FDA would have sent a legal notice to $HIMS. What I personally expect is a PR from the company saying that they are financially and legally doing fine.
1 · Reply
Latest News on NOV
NOV: Growth Proposition Intact Despite Near-Term Headwind

Jul 9, 2025, 12:47 AM EDT - 6 days ago

NOV: Growth Proposition Intact Despite Near-Term Headwind

NOV Announces Second Quarter 2025 Earnings Conference Call

Jun 27, 2025, 6:30 AM EDT - 18 days ago

NOV Announces Second Quarter 2025 Earnings Conference Call

NOV Declares Regular Quarterly Dividend and Supplemental Dividend

May 21, 2025, 6:30 AM EDT - 7 weeks ago

NOV Declares Regular Quarterly Dividend and Supplemental Dividend

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:44 PM EDT - 2 months ago

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

NOV Reports First Quarter 2025 Results

Apr 28, 2025, 5:45 PM EDT - 2 months ago

NOV Reports First Quarter 2025 Results

NOV Announces Key Leadership Changes

Mar 19, 2025, 5:00 PM EDT - 4 months ago

NOV Announces Key Leadership Changes

NOV Declares Regular Quarterly Dividend

Feb 21, 2025, 6:30 AM EST - 5 months ago

NOV Declares Regular Quarterly Dividend

NOV: Shareholder Returns Have Likely Peaked For Now

Feb 7, 2025, 3:21 PM EST - 5 months ago

NOV: Shareholder Returns Have Likely Peaked For Now

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 3:12 PM EST - 5 months ago

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

Feb 4, 2025, 5:45 PM EST - 5 months ago

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

NOV Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

Dec 23, 2024, 6:30 AM EST - 7 months ago

NOV Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

NOV Appoints Chris Kendall to the Board of Directors

Dec 16, 2024, 6:30 AM EST - 7 months ago

NOV Appoints Chris Kendall to the Board of Directors

The Big 3: DJT, JD, NOV

Dec 5, 2024, 12:27 PM EST - 7 months ago

The Big 3: DJT, JD, NOV

DJT JD

Venture Builder VC Launches NOV Supernova Accelerator to Drive Digital Transformation in Upstream Oil & Gas with Disruptive Startups

Nov 12, 2024, 2:11 PM EST - 8 months ago

Venture Builder VC Launches NOV Supernova Accelerator to Drive Digital Transformation in Upstream Oil & Gas with Disruptive Startups

These Analysts Lower Their Forecasts On NOV Following Q3 Results

Oct 28, 2024, 11:06 AM EDT - 9 months ago

These Analysts Lower Their Forecasts On NOV Following Q3 Results

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 2:55 PM EDT - 9 months ago

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

NOV Reports Third Quarter 2024 Results

Oct 24, 2024, 5:45 PM EDT - 9 months ago

NOV Reports Third Quarter 2024 Results

14 energy stocks whose ample cash flow might benefit shareholders

Sep 30, 2024, 11:11 AM EDT - 10 months ago

14 energy stocks whose ample cash flow might benefit shareholders

BTU CHRD COP DVN FANG HAL LBRT

NOV Announces Third Quarter 2024 Earnings Conference Call

Sep 23, 2024, 6:30 AM EDT - 10 months ago

NOV Announces Third Quarter 2024 Earnings Conference Call

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

Jul 26, 2024, 3:27 PM EDT - 1 year ago

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

NOV Reports Second Quarter 2024 Results

Jul 25, 2024, 6:00 PM EDT - 1 year ago

NOV Reports Second Quarter 2024 Results

6 Stocks That Have Come Too Far, Too Fast

Jul 22, 2024, 11:23 AM EDT - 1 year ago

6 Stocks That Have Come Too Far, Too Fast

BJRI COOP CUBI MXL SAH

NOV: A Top Oil And Gas Services Pick Under Quiet Accumulation

Jul 9, 2024, 5:28 PM EDT - 1 year ago

NOV: A Top Oil And Gas Services Pick Under Quiet Accumulation

NOV Announces Second Quarter 2024 Earnings Conference Call

Jun 21, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Second Quarter 2024 Earnings Conference Call

NOV Announces 50 Percent Increase in Regular Quarterly Dividend

May 16, 2024, 6:30 AM EDT - 1 year ago

NOV Announces 50 Percent Increase in Regular Quarterly Dividend

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

Apr 26, 2024, 3:50 PM EDT - 1 year ago

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50%

Apr 25, 2024, 6:09 PM EDT - 1 year ago

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50%

Bullish on NOV

Apr 15, 2024, 1:14 PM EDT - 1 year ago

Bullish on NOV

Arcosa, Inc. Announces Completion of Ameron Acquisition

Apr 9, 2024, 4:15 PM EDT - 1 year ago

Arcosa, Inc. Announces Completion of Ameron Acquisition

ACA

NOV Announces First Quarter 2024 Earnings Conference Call

Mar 26, 2024, 6:30 AM EDT - 1 year ago

NOV Announces First Quarter 2024 Earnings Conference Call

Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.

Mar 11, 2024, 8:00 AM EDT - 1 year ago

Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.

ACA

NOV Announces Opening of Regional Headquarters in Dammam, Saudi Arabia

Feb 22, 2024, 4:34 PM EST - 1 year ago

NOV Announces Opening of Regional Headquarters in Dammam, Saudi Arabia

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

Feb 2, 2024, 1:58 PM EST - 1 year ago

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

NOV Reports Fourth Quarter and Full Year 2023 Earnings

Feb 1, 2024, 5:30 PM EST - 1 year ago

NOV Reports Fourth Quarter and Full Year 2023 Earnings

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

Oct 27, 2023, 12:37 PM EDT - 1 year ago

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

NOV Reports Third Quarter 2023 Earnings

Oct 26, 2023, 5:00 PM EDT - 1 year ago

NOV Reports Third Quarter 2023 Earnings

NOV Announces Third Quarter 2023 Earnings Conference Call

Sep 12, 2023, 11:48 AM EDT - 2 years ago

NOV Announces Third Quarter 2023 Earnings Conference Call

Selling Time? Oil, Inflation, Debt Concerns And A T-Bill Portfolio

Aug 15, 2023, 11:00 AM EDT - 2 years ago

Selling Time? Oil, Inflation, Debt Concerns And A T-Bill Portfolio

BBSA BIL BILS DIA EDV EGF EWJ

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 3:44 PM EDT - 2 years ago

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

NOV Reports Second Quarter 2023 Earnings

Jul 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Second Quarter 2023 Earnings

NOV Announces Second Quarter 2023 Earnings Conference Call

Jun 13, 2023, 6:00 PM EDT - 2 years ago

NOV Announces Second Quarter 2023 Earnings Conference Call

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NOV Inc. and Encourages Investors with Losses to Contact the Firm

May 3, 2023, 9:30 AM EDT - 2 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NOV Inc. and Encourages Investors with Losses to Contact the Firm

NOV Inc. (NOV) Q1 2023 Earnings Call Transcript

Apr 27, 2023, 4:20 PM EDT - 2 years ago

NOV Inc. (NOV) Q1 2023 Earnings Call Transcript

NOV Reports First Quarter 2023 Earnings

Apr 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports First Quarter 2023 Earnings

NOV: 2023 Off To A Bad Start

Mar 27, 2023, 5:43 PM EDT - 2 years ago

NOV: 2023 Off To A Bad Start

NOV: Shares Still A Value Ahead Of Earnings, At A Key Spot Technically

Mar 27, 2023, 11:36 AM EDT - 2 years ago

NOV: Shares Still A Value Ahead Of Earnings, At A Key Spot Technically

NOV Announces First Quarter 2023 Earnings Conference Call

Mar 10, 2023, 4:02 PM EST - 2 years ago

NOV Announces First Quarter 2023 Earnings Conference Call

NOV Inc. (NOV) Q4 2022 Earnings Call Transcript

Feb 7, 2023, 3:38 PM EST - 2 years ago

NOV Inc. (NOV) Q4 2022 Earnings Call Transcript

NOV Reports Fourth Quarter and Full Year 2022 Results

Feb 6, 2023, 5:00 PM EST - 2 years ago

NOV Reports Fourth Quarter and Full Year 2022 Results

Solaryellow
Solaryellow Jul. 15 at 12:54 PM
$IXHL third time Ive seen mention or reference, of an # $NOV buy or merger...
1 · Reply
TandoriAmerica
TandoriAmerica Jul. 11 at 11:36 PM
$NOV $150 2027 I said it here.
0 · Reply
Blackberry_Buzz
Blackberry_Buzz Jul. 10 at 5:39 PM
$NOV Good God. Someone just spent over $1.2M in premium for the Nov 14 strike calls & $100K for some Aug 16 strike calls today. You're now about the daily 89 moving average and 21 moving average. Looks strong.
0 · Reply
TheDayTradingAcademy
TheDayTradingAcademy Jul. 9 at 1:32 AM
European stock markets were higher on Tuesday, boosted by energy up +1.1%, due by higher crude prices & healthcare shares up +0.08%, with $NOV up +2%, while investors assessed the latest round of U.S. President Trump's tariff rollouts, which included a new deadline for trade deals which is Aug.01. French $CAC40 +0.56%, German $DAX +0.55%, Italian FTSE +0.67%, Spain’s Ibex +0.03%, London $FTSE +0.54% & European STOXX 600 +0.41% at 545.71, its highest level in 3 weeks.
0 · Reply
tnewman913
tnewman913 Jul. 1 at 7:07 PM
$NOV the adr for novo nordisk is NVO not NOV. NOV is energy, nerds.
0 · Reply
JarvisFlow
JarvisFlow Jul. 1 at 3:58 PM
Susquehanna has updated their rating for NOV ( $NOV ) to Positive with a price target of 18.
0 · Reply
Doozio
Doozio Jul. 1 at 4:23 AM
$HAL is fooked MRNA then PFE. Wait until $NOV.
0 · Reply
clan
clan Jun. 29 at 1:33 AM
$MNKD CLOFAZIMINE (CIS) by Mannkind ----------------------------------------------------- Designations: - Phase 3 ICoN-1 international trials • U.S.A. & Japan & Australia & Korea - Fast Tracked by FDA - Orpan Drug - Qualified Infectious Disease Product - Well tolerated - No significant Adverse Events - Localized treatment (lungs) - Improved patient adherence - Indications for arthritis & cancers - Current global mkt $2.1B [2023] ...and coming soon..... - - - Clofazimine DPI Partner with $GSK ? $NOV ? $ROCHE ? Maybe Merck.
1 · Reply
lenhat
lenhat Jun. 27 at 2:09 PM
$HIMS $NOV is a clown. Hims is a growing business💪
1 · Reply
smalltraderjoe
smalltraderjoe Jun. 25 at 9:40 PM
$HIMS $NOV sells wegovy which is nothing but a branded GLP-1. They were forcing $HIMS to sell only wegovy over $HIMS own compounded- GLP-1 . Over the period of time this practice would kill the profit of HIMS. $HIMS's custom GLP-1 products are not illegal and within the limit of FDA designated specs. Otherwise by this time FDA would have sent a legal notice to $HIMS. What I personally expect is a PR from the company saying that they are financially and legally doing fine.
1 · Reply
FractionalShareWhale
FractionalShareWhale Jun. 25 at 6:30 PM
$NOV 🚨 buy it !!!!
0 · Reply
CHR15M
CHR15M Jun. 24 at 12:21 PM
$HIMS $NOV the truth likely lies somewhere in the middle
0 · Reply
CHR15M
CHR15M Jun. 24 at 12:17 PM
$HIMS CEOs Response to $NOV actions
0 · Reply
myman1956
myman1956 Jun. 24 at 5:09 AM
$HIMS The CEO has been lying saying $NOV is misleading which the facts are that $NOV doesn't need $HIMS in any shape. That downgrades to $15.00 is the reason why so many last week sold at highs that $NOV let the cat out of the bag last week saying cancel all deals last week. That men doesn't even like the hair products that doesn't work is another product that doesn't work.
2 · Reply
AMUNRATHEBLACKGOD
AMUNRATHEBLACKGOD Jun. 23 at 12:43 PM
$HIMS $NOV said it is ”concern” about glp-1 knocks put users at risk…..so what happens when it comes off patent?!….. 5-10% of $HIMS revenues is glp-1s
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 12:34 PM
$NOV down 24% over the past year — time to hold or fold? ⚠️ The drop tracks mounting pressures from tariffs, soft demand, and rising corporate costs. Full risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2534898/nov-stock-down-24-in-a-year-should-investors-hold-or-move-on?cid=sm-stocktwits-2-2534898-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2534898_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 11:35 AM
Is $NOV facing a structural challenge or just a temporary setback? 🤔 The Zacks Rank #5 stock missed Q1 earnings estimates, with adjusted EPS at 19 cents vs. the expected 25 cents. Margin challenges in the Energy Equipment division, declining net income due to higher costs, and macroeconomic risks are adding pressure. 📉 Discover whether NOV is a hold or a sell 👉 https://www.zacks.com/commentary/2534898/nov-stock-down-24-in-a-year-should-investors-hold-or-move-on?cid=sm-stocktwits-2-2534898-body&ADID=SYND_STOCKTWITS_TWEET_2_2534898_BODY
0 · Reply
Mpete
Mpete Jun. 16 at 6:13 PM
$NOV Nice blessing with that Divvy. How do you know when those are coming? I had no idea
0 · Reply
Dsharky
Dsharky Jun. 16 at 1:41 PM
$NOV looks like the special dividend didn't qualify for DRIP?
1 · Reply
Traderatodds
Traderatodds Jun. 14 at 6:54 PM
$NOV did anyone in here work at the anaehim/orange plant?
0 · Reply
JarvisFlow
JarvisFlow Jun. 5 at 1:00 PM
Wells Fargo has updated their rating for NOV ( $NOV ) to Underweight with a price target of 10.
1 · Reply
WallStreetPro2021
WallStreetPro2021 May. 31 at 10:18 PM
$NOG $EPM $NOV $COP Piper Sandler issues a $11.00 price target on PROP – Prairie Operating, trading at $3.87 a share. Upstream producer Prairie Operating Company (PROP), lots of insider buys in the last two weeks as their acquisition on Bayswater completed and significant production was added. They are well hedged at $68.27 a barrel for 2025 and from Q1 2026 thru Q1 2028 at $64.29 a barrel. Piper Sandler issues a $11.00 price target, trading at $3.87 a share. https://www.investing.com/news/analyst-ratings/piper-sandler-sets-11-target-for-prairie-operating-stock-93CH-4011820 Actual Piper Sandler 31- page analysis attached https://storage.googleapis.com/vendorgroup-assets/site/4308a1c5-ae18-4626-847f-4861aa44b367/2025/04/30/681255b42f7fb57b7c7e7cd2/Piper-Sandler-4.30.25.pdf
0 · Reply